Skip to content
Use caution Medical device recall · FDA · Published December 16, 2020

Medtronic Neonatal Delta Valve Recall: Risk of Shunt Disconnection

Medtronic recalls neonatal Delta Valve shunt components due to potential shunt malfunction from improper valve connection. Affected units have a shorter ventricular catheter connection site than designed.

🇺🇸 FDA recall #Z-0872-2021Medical deviceMedtronic ›
Take action

Contact the company

Recalling firmMedtronic Neurosurgery5290 California Ave · Irvine, CA 92617-3073
✎ GovInfoNow plain-language explainer

What happened, in plain English

Medtronic is recalling neonatal Delta Valve shunt components because they may not connect securely to the catheter, risking shunt malfunction. This could affect infants with brain fluid drainage systems. Read more at govinfonow.com/recall/63649-medtronic-neonatal-delta-valve-recall-risk-of-shunt-disconnection.

Source Summary by GovInfoNow · govinfonow.com/recall/63649-medtronic-neonatal-delta-valve-recall-risk-of-shunt-disconnection · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0872-2021

Cite this page

“Medtronic Neonatal Delta Valve Recall: Risk of Shunt Disconnection.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/63649-medtronic-neonatal-delta-valve-recall-risk-of-shunt-disconnection. Based on FDA recall #Z-0872-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0872-2021%22&limit=1).

Why it’s dangerous

The neonatal valve has a shorter ventricular catheter connection site than designed, which can cause the valve to disconnect from the catheter. This disconnection may lead to shunt malfunction, potentially causing brain fluid buildup or other complications.

Who’s affected

Parents and caregivers of infants using Medtronic neonatal shunt systems are most at risk. The affected product is used for brain fluid drainage in newborns.

How to tell if you have this one

Check for the product name 'Delta Valve', model 'X1', and lot number 0219281777. These components are part of neonatal shunt systems for brain fluid drainage.

  • Brand
    Medtronic
  • Category
    Medical device
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Worldwide distribution - US Nationwide distribution including in the states of AL, AZ, CA, CO, FL, GA, IL, KS, KY, LA, MA, MI, MO, NV, NM, NY, ND, OH, OK, TN, VA and the countries of Albania, Australia, Brazil, Cyprus, Ireland, Mexico, Qatar, Romania, Russian Federation, Serbia, South Africa, Spain, United Kingdom.
Recall numberProduct, codes & lotsQuantity
Z-0871-2021REF 27219-1 X1, Medtronic, Delta Valve, Neonatal, Performance Level 1.0, CE 0344, Sterile EO - Product Usage: Neonatal Delta Snap Shunt Assemblies are components of CSF-Flow Control Shunt Systems designed to provide controlled CSF flow from the ventricles of the brain into the peritoneal cavity.; Lot # 0219927059, 0220149614, 0220393237, 0220601648,0220601649, 022081302995 units
Z-0872-2021REF 27219-2 X1, Medtronic, Delta Valve, Neonatal, Performance Level 2.0, CE 0344, Sterile EO - Product Usage: Neonatal Delta Snap Shunt Assemblies are components of CSF-Flow Control Shunt Systems designed to provide controlled CSF flow from the ventricles of the brain into the peritoneal cavity.; Lot # 0219281777N/A
Z-0873-2021REF 27219-5 X1, Medtronic, Delta Valve, Neonatal, Performance Level 1.5, CE 0344, Sterile EO - Product Usage: Neonatal Delta Snap Shunt Assemblies are components of CSF-Flow Control Shunt Systems designed to provide controlled CSF flow from the ventricles of the brain into the peritoneal cavity.; Lot # 0219948893, 0220166870, 0220236215, 0220704352, 0220720015, 0220752505N/A
Based on the official FDA remedy

What to do — step by step

  1. Check Shunt Connection

    Inspect the valve for a shorter ventricular catheter connection site than expected. If disconnected, contact your healthcare provider immediately.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 21 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: named in the noticeNDMinnesota: nationwideMNIllinois: named in the noticeILWisconsin: nationwideWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: named in the noticeMAOregon: nationwideORNevada: named in the noticeNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: nationwideINOhio: named in the noticeOHPennsylvania: nationwidePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: named in the noticeCAUtah: nationwideUTColorado: named in the noticeCONebraska: nationwideNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: nationwideWVVirginia: named in the noticeVAMaryland: nationwideMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: nationwideARTennessee: named in the noticeTNNorth Carolina: nationwideNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: nationwideMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: nationwideHITexas: nationwideTXFlorida: named in the noticeFL

FDA distribution: “Worldwide distribution - US Nationwide distribution including in the states of AL, AZ, CA, CO, FL, GA, IL, KS, KY, LA, MA, MI, MO, NV, NM, NY, ND, OH, OK, TN, VA and the countries of Albania, Australia, Brazil, Cyprus, Ireland, Mexico,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arizona, California, Colorado, Florida, Georgia, Illinois, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Missouri, Nevada, New Mexico, New York, North Dakota, Ohio, Oklahoma, Tennessee, Virginia.

Recall timeline

FDA published this recall 42 days after the firm started it.

1. Firm started the recall: Dec 16, 202012. FDA classified it Class II: Jan 15, 202123. Published in FDA’s Enforcement Report: Jan 27, 2021320202021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0872-2021 (December 16, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0872-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA